Is Oura losing its lead to Whoop?

Last updated: 21 October 2026
Cover of NewMarketPitch's digital health report

Building a startup or looking for your next investment in digital health? Our report gives you the full picture.

Summary

No. Oura is not losing its lead to Whoop. It has roughly twice as many paying members, faster-than-ever membership expansion, and a profitable business with strong cash generation. Whoop is catching up in valuation and health-monitoring capabilities, but there is no convincing evidence that it is taking meaningful market share from Oura.

The valuation gap has almost disappeared. Whoop raised $575 million at a $10.1 billion valuation in March 2026, close to Oura's $11 billion private valuation in 2025. Investors are assigning nearly equal values to businesses with very different customer bases and financial transparency.

Oura's scale advantage remains substantial. It reported 5 million paid members in June 2026, versus more than 2.5 million for Whoop in March. Closing that gap would require Whoop to add roughly as many members as it had accumulated over its entire history.

Whoop's headline growth numbers look stronger at first glance, but the comparison is misleading. Its bookings grew 103% in 2025, while Oura's nine-month revenue increased 74%. Bookings and recognized revenue measure different things, and Oura's own paid-member count has more than tripled since the end of 2024.

Oura's financial disclosure creates another advantage: we know its economics actually work. It generated $1.21 billion in nine-month revenue, $60.8 million in net income, and approximately $262 million in free cash flow. Whoop has reported positive operating cash flow, but not comparable profitability figures.

The companies are winning different customers. Whoop has a stronger identity among serious athletes who prioritize training strain and recovery. Oura has built a broader health-monitoring business, particularly among women, who account for approximately 72% of its members.

Oura's customer loyalty makes a sudden competitive reversal less likely. Its disclosed twelve-month paid-member retention is approximately 85%, with a daily-to-monthly active-user ratio near 65%. Those figures do not suggest a customer base abandoning smart rings for performance bands.

Whoop's international growth may be its best opportunity to narrow the gap. About 60% of its new sales reportedly come from outside the United States, while international markets account for less than 20% of Oura's hardware revenue. The measures differ, but Whoop appears particularly effective at reaching new overseas customers.

The subscription economics are closer than they look. Three years with an entry-level Oura Ring 5 costs about $609, compared with $597 for Whoop One and $717 for Whoop Peak. Whoop collects more recurring revenue per subscriber, while Oura receives a substantial hardware payment upfront.

Meanwhile, the competitive threat extends far beyond these two companies. Apple, Garmin, Samsung, RingConn, and Ultrahuman are challenging different parts of the health-wearables market. Oura remains ahead of Whoop commercially, but neither company can assume that its current niche will remain protected.

Written by the New Market Pitch teamWe track new markets so founders and investors can move faster. About us

Chart of a key cost in the digital health market against a reference line: The Wegovy pill now costs $149 a month, less than Hims & Hers' $199 copy (Digital Health Market, NewMarketPitch)

When the price drops below the right threshold, everything speeds up. We track it closely in our digital health market report.

Is Whoop actually catching Oura?

Whoop is getting closer to Oura in business value and product capabilities, but Oura still has a commanding lead in paying customers. Both companies are growing fast, and the available figures show no sign that Oura's business is slowing down because of Whoop.

The rivalry has become more interesting since Whoop raised $575 million at a $10.1 billion valuation in March 2026. The company reported more than 2.5 million members and said its bookings had grown 103% in 2025. Oura, meanwhile, filed for an IPO in September 2026, revealing 5 million paid members as of June and $1.21 billion in revenue over the preceding nine months.

The two companies have reached similar valuations while selling different products. Oura focuses on discreet, continuous health monitoring through a smart ring. Whoop has built its reputation around a screenless wearable that helps athletes understand training strain, recovery, and sleep.

Whoop is now moving deeper into preventive health, which brings it into more direct competition with Oura. But so far, both companies appear to be expanding into each other's territory rather than stealing large numbers of customers from one another.

If you want more recent data on this point, please see our latest digital health market report.

What would it take for Whoop to overtake Oura?

Whoop would need to close Oura's enormous membership gap while proving that its more expensive subscriptions can support a bigger business over time. Its popularity among professional athletes is already well established, but that represents only one part of the health-wearables market.

The distinction comes from how the two products are used. Oura is particularly strong in sleep monitoring, women's health, and tracking physiological changes over long periods. Whoop concentrates on exercise, recovery, sleep requirements, and behavioral coaching.

The numbers that would settle this are paying members, customer growth, retention, revenue, and profitability. Product reviews and athlete endorsements provide context, but they cannot tell us which company is winning commercially.

Oura has published detailed financial information through its SEC filing, while Whoop remains privately held. We have substantially better visibility into Oura's finances, making any claim that Whoop has already overtaken it difficult to defend.

How much bigger is Oura than Whoop today?

Oura currently has about twice as many paying members as Whoop's last publicly reported total, making it the larger platform by a considerable margin.

Oura disclosed 5 million paid members at the end of June 2026, compared with more than 2.5 million members reported by Whoop in March. The reporting dates differ, but the gap is large enough to establish the approximate difference in scale.

For Whoop to reach Oura's reported level, it would need to add roughly another 2.5 million members beyond its March total. That is approximately as many members as Whoop had accumulated throughout its history up to that point.

Financially, the difference is smaller. Oura generated $907.9 million in fiscal 2025 revenue and $1.21 billion during the nine months ending June 2026. Whoop said it exited 2025 with an annualized bookings run rate of $1.1 billion.

Those numbers need careful interpretation. Whoop's annualized bookings measure the pace of customer commitments at a particular point, whereas Oura's figures represent recognized revenue over completed reporting periods.

Metric Oura Whoop
Reported members 5M paid members, June 2026 More than 2.5M, March 2026
Recent growth 74% revenue growth over comparable nine-month periods 103% bookings growth in 2025
Reported financial scale $1.21B revenue over nine months $1.1B annualized exit bookings
Private valuation benchmark $11B in 2025 $10.1B in March 2026
Main device Smart ring Wrist/body-worn sensor
Business model Hardware purchase plus membership Membership with hardware included
Standard annual membership $69.99 $199–$359
Disclosed 12-month retention Approximately 85% Not publicly disclosed on a comparable basis
Chart of how widely a technology of the digital health market has been adopted over time: Medicare telehealth stalled at 1 in 4, after peaking at 47.9% in 2020 (Digital Health Market, NewMarketPitch)

Adoption is moving faster than many people realize. Our digital health market report shows where this market is on the curve.

Is Whoop growing faster than Oura?

Whoop's bookings are growing extremely fast, but Oura's membership growth is just as striking. We don't have enough comparable financial information to declare Whoop the faster-growing business overall.

Whoop reported 103% bookings growth in 2025, an impressive result for a company founded in 2012. Its annualized exit bookings reached $1.1 billion, suggesting that the company entered 2026 at a much larger commercial scale than before.

Oura's SEC filing provides a more detailed picture. Its paid-member count increased from approximately 1.5 million at the end of 2024 to 5 million by June 2026. The company also reported more than 100% year-over-year paid-member growth for seven consecutive quarters.

Meanwhile, Oura's revenue climbed from $697.6 million to $1.21 billion across comparable nine-month periods, an increase of around 74%.

There's an interesting gap here: Oura's membership base has been growing faster than its recognized revenue. Its recurring customer relationship is becoming more important as millions of new users join the platform.

One caveat is important. Bookings can include prepaid memberships and commitments that are recognized as revenue later. Comparing Whoop's 103% bookings growth directly against Oura's 74% revenue growth would give a misleading impression of which company is expanding faster.

Both businesses are growing exceptionally quickly. Oura simply provides a more complete financial record.

Is Oura still dominating the smart-ring market?

Oura remains the leading specialist smart-ring company, and Whoop has done little to challenge that particular advantage because it primarily sells a different kind of wearable.

IDC's 2026 outlook projected 4.9 million smart-ring shipments worldwide, up 12.8% from the previous year, and identified Oura as the category's anchor brand.

Oura also reported selling 3.6 million rings during the twelve months ending June 2026. That is an enormous volume for a relatively specialized wearable. However, we cannot calculate a precise market share by dividing this figure by IDC's forecast because the reporting periods and potentially the shipment definitions differ.

The more direct competitors are Samsung Galaxy Ring, RingConn, and Ultrahuman. These companies compete with Oura on the same form factor, with some emphasizing lower ownership costs or avoiding recurring subscriptions.

Whoop competes differently. It can persuade someone who wants continuous health monitoring to choose a performance-focused wristband instead of a ring, but there is no evidence that its growth has reduced Oura's share of smart-ring sales.

Bar chart comparing Had a video visit and Did not: How many Americans already see their doctor on video? (Digital Health Market, NewMarketPitch)

Market size is where every investment case starts. Get the full picture in our digital health market report.

Is Whoop now the favorite wearable among serious athletes?

Whoop has built one of the strongest reputations in performance-focused wearables, particularly among athletes who pay close attention to training, recovery, and sleep. Oura has not matched Whoop's positioning in this part of the market.

Whoop's software revolves around daily strain, recovery estimates, sleep debt, and workout tracking. For people who organize their schedules around exercise, these measurements are central to the product rather than secondary features.

The company's relationships with elite athletes have reinforced that identity for years. Its March 2026 financing included investors such as Cristiano Ronaldo, LeBron James, Rory McIlroy, and Virgil van Dijk. These connections give Whoop unusually strong visibility among performance-oriented consumers.

The 2026 Australian Open provided another example when restrictions involving Whoop devices worn by prominent tennis players attracted attention. That controversy showed how visible the product had become in professional sport, although it tells us little about total consumer adoption.

Oura offers activity tracking, recovery information, and integrations with platforms such as Strava. Still, its proposition is broader, particularly for people interested in sleep, general health, or long-term physiological changes.

For consumers who want a wearable primarily to support structured training, we'd give Whoop the advantage. That athletic reputation hasn't yet translated into a larger customer base, though, and we don't know whether its users are more loyal.

If you want more recent data on this point, please see our latest digital health market report.

Does Oura still track sleep and recovery better than Whoop?

Oura has demonstrated better accuracy than Whoop in some independent overnight measurements, particularly resting heart rate and heart-rate variability. The evidence is strongest for the device generations that researchers actually tested.

A 2025 study published in Physiological Reports compared Oura Generation 3, Oura Generation 4, Whoop 4.0, and other wearables against electrocardiogram recordings across 536 nights involving 13 participants.

Oura Generation 4 recorded a mean absolute percentage error of approximately 1.94% for resting heart rate and 5.96% for heart-rate variability. Whoop 4.0 recorded 3.00% and 8.17%, respectively.

Both companies use these physiological measurements to support their recovery and readiness estimates. Smaller measurement errors can improve the reliability of the underlying inputs, although the resulting proprietary scores involve additional calculations.

The study has limitations. It involved a small participant sample, and Whoop 5.0 and MG were not included. We cannot automatically extend the results to the companies' newest hardware.

Other sleep-laboratory research has supported Whoop's ability to estimate sleep duration and timing. Both products still face limitations in sleep-stage classification compared with clinical polysomnography.

The evidence favors Oura on the overnight measurements tested, but the latest hardware generations have not been compared comprehensively enough to establish an undisputed winner.

Line chart comparing worldwide Google searches with the number of funding rounds raised by digital health startups each month since January 2024: Searches for GLP-1 drugs tripled, but digital health rounds barely grew (Digital Health Market, NewMarketPitch)

Is investor excitement matched by real public interest? Find out in our digital health market report.

Has Whoop 5.0 caught up with Oura's hardware?

Whoop 5.0 has closed several important hardware gaps, especially around battery life and health monitoring, although Oura still offers something Whoop cannot replicate: a discreet smart ring that can be worn alongside a conventional watch.

Whoop introduced its 5.0 and MG generation in May 2025, adding cardiovascular monitoring, healthspan features, and longer battery operation. Whoop MG also introduced ECG capabilities in eligible markets.

Oura subsequently introduced Ring 5 in 2026, with a thinner titanium design and approximately 40% less volume than Ring 4, according to the company's specifications.

The form factor creates practical differences that software upgrades cannot easily remove. Weightlifters and contact-sport athletes may find a ring uncomfortable or impractical during training. Whoop's wrist and body-worn options offer more flexibility in those situations.

On the other hand, Oura lets someone wear an ordinary watch while collecting health data continuously. That is appealing to consumers who dislike another visible wrist device.

Both companies have improved their sensors and expanded their health features. For many buyers, the deciding factor will simply be which device they can comfortably wear every day.

Is Whoop's subscription model better than Oura's?

Whoop earns much more membership revenue per customer at standard prices, but Oura collects significant hardware revenue upfront and charges far less for ongoing access. Neither approach has been proven economically superior across the entire customer relationship.

Whoop's advertised U.S. annual plans include One at $199, Peak at $239, and Life at $359, generally with hardware included. Oura sells Ring 5 from $399 and charges $69.99 annually or $5.99 monthly for membership.

Over three years, an entry-level Oura Ring 5 with annual membership costs approximately $609 before tax, assuming the customer keeps the same ring. Whoop One costs $597, Peak costs $717, and Life costs $1,077 over the same period.

Interestingly, Oura's subscription business is becoming more valuable in its own right. Membership revenue increased from $75.5 million in fiscal 2024 to $158.5 million in fiscal 2025, and reached $240.5 million during the first nine months of fiscal 2026.

That latest figure represented approximately 19.8% of Oura's total revenue over the period. Hardware still brings in most of the money, but the subscription business is expanding rapidly.

Whoop's model creates substantial recurring revenue potential, especially when users subscribe to higher-priced plans. The company also has to cover hardware and servicing costs through those payments.

Three-year cost Oura Ring 5 Whoop One Whoop Peak Whoop Life
Starting hardware price $399 Included Included Included
Annual membership $69.99 $199 $239 $359
End of year 1 $468.99 $199 $239 $359
End of year 2 $538.98 $398 $478 $718
End of year 3 $608.97 $597 $717 $1,077
Total membership spending $209.97 $597 $717 $1,077
Hardware purchased separately Yes No No No

Based on standard advertised U.S. prices, excluding taxes, promotions, and additional purchases.

Bar chart comparing Digital health and All other health spending: What slice of health spending goes to digital health? (Digital Health Market, NewMarketPitch)

How big is this market really? Our digital health market report sizes it with numbers you can check.

Are Oura customers abandoning their rings for Whoop?

There is no convincing evidence of a large-scale switch from Oura to Whoop. Oura's disclosed retention and engagement figures instead suggest that most customers continue using the platform after joining.

According to Oura's September 2026 SEC filing, its weighted-average twelve-month paid-member retention was approximately 85% as of June. Historically, more than 94% of ring activations converted into paid memberships after the initial trial.

The company also reported a daily-active-to-monthly-active user ratio of approximately 65% during the first three quarters of fiscal 2026.

Taken together, these figures indicate that Oura has built a service people keep paying for and regularly use. The company certainly loses some customers, but its retention numbers do not point to a widespread rejection of the product.

We have less visibility into Whoop. Its annual membership structure encourages longer commitments, while comparable public data on twelve-month retention is unavailable.

Some consumers may own both devices or switch between them depending on their priorities. Without independent switching surveys or comparable customer-cohort data, we cannot reliably attribute Whoop's new memberships to customers leaving Oura.

Is women's health becoming Oura's biggest advantage over Whoop?

Women's health has become one of Oura's clearest competitive strengths, and the scale of its female customer base is something Whoop has yet to match publicly.

Oura reported that approximately 72% of its members were women as of June 2026. Applied to its disclosed base of 5 million paid members, that suggests around 3.6 million female members, subject to rounding and consistency between the reported populations.

The company has built features around cycle tracking, fertility-related insights, pregnancy, postpartum health, and long-term physiological monitoring. Its partnerships with Natural Cycles and Maven Clinic extend that offering beyond the ring's own software.

What's particularly interesting is the growth rate. Oura disclosed compound annual membership growth of approximately 143% among women and 94% among men since fiscal 2024.

Both groups were growing quickly, but women were joining much faster. Oura is attracting a large audience beyond the customers traditionally associated with sports wearables.

Whoop has also expanded its health offerings, including features for different physiological needs. However, it has not disclosed comparable female membership figures or demonstrated an equally large reproductive-health ecosystem.

This may be harder for Whoop to challenge than Oura's lead in sleep tracking. Features can be copied, but building an established network of users, clinical partners, and specialized health services takes time.

If you want more recent data on this point, please see our latest digital health market report.

Chart of the market share of the leading companies of the digital health market: Hims & Hers now outsells Teladoc, which was 7.5x bigger in 2021 (Digital Health Market, NewMarketPitch)

Market share tells you more than funding headlines. See who leads in our digital health market report.

Is Whoop becoming a serious competitor in preventive healthcare?

Whoop is becoming a serious preventive-health competitor, and its recent product launches show that the company wants to do much more than help athletes recover after training.

Whoop MG introduced ECG and related cardiovascular features in supported markets, while Healthspan uses physiological information to generate age-related health indicators. Advanced Labs adds blood testing to the company's broader health offering.

Its March 2026 financing also included Abbott and Mayo Clinic among the named participants. These relationships bring Whoop closer to organizations with expertise in diagnostics, healthcare, and clinical research.

Oura has been building a similar ecosystem through partnerships with Dexcom, Natural Cycles, and healthcare providers. Its September 2026 SEC filing described a network of more than 1,200 partners.

The companies are increasingly targeting the same consumer question: how can continuous physiological monitoring help people make better long-term health decisions?

There is still a meaningful difference in how they approach medical features. Whoop MG offers ECG capabilities in eligible markets, while Oura generally positions its ring as a wellness product supported by specialized healthcare partnerships.

Whoop's Blood Pressure Insights feature also attracted regulatory scrutiny. The FDA warned the company in July 2025 about marketing the feature without appropriate authorization. In June 2026, the agency closed the matter after modifications to the product and labeling under its general wellness policy. That action did not amount to FDA clearance of the feature.

Whoop has made genuine progress toward broader health monitoring, but medical credibility will depend on validated capabilities and clinical outcomes rather than the number of features released.

Is Oura making more money than Whoop?

Oura has demonstrated a profitable business at considerable scale, while Whoop's private disclosures make a precise financial comparison impossible. On the evidence available, Oura has the stronger documented financial position.

Oura reported $1.21 billion in revenue during the nine months ending June 2026, up approximately 74% from the comparable period. Net income reached around $60.8 million, with adjusted EBITDA of $106.7 million.

Its gross margin was approximately 54.5%. Operating cash flow reached about $328 million, and after roughly $66 million in capital expenditure, the company generated approximately $262 million in free cash flow using the simple operating-cash-flow-minus-capex method.

Those results are impressive for a business where hardware still accounts for roughly four-fifths of revenue. Oura has shown that selling physical devices alongside subscriptions can produce meaningful profits and cash generation.

Whoop reported becoming operating-cash-flow positive during 2025 and disclosed an annualized exit bookings run rate of $1.1 billion. That is encouraging, especially after several years of investment in hardware, software, and customer acquisition.

However, Whoop has not published comparable figures for recognized revenue, gross margin, net income, or annual operating cash flow. We cannot calculate whether its customers are more profitable or whether its membership pricing creates better margins.

For now, Oura's financial strength is measurable. Whoop's profitability remains much less transparent.

If you want more recent data on this point, please see our latest digital health market report.

Chart of where each dollar paid by a customer goes in the digital health market: Hims & Hers spent 1.5x as much on marketing as on the care it sold (Digital Health Market, NewMarketPitch)

Some business models leave very little on the table. Find out which ones in our digital health market report.

Is Whoop now worth almost as much as Oura?

Whoop has nearly matched Oura's historical private valuation, even though Oura has roughly twice its last reported membership count. That makes Whoop's $10.1 billion financing one of the clearest signs of how much investor expectations have changed.

Whoop reached its valuation in March 2026 through a $575 million Series G financing. Oura had been valued at approximately $11 billion in 2025.

The gap between those two private valuations is less than 10%, but they were established at different times and under different market conditions. They are also influenced by preferred-share terms and investor expectations.

Whoop's valuation is equivalent to approximately 9.2 times its disclosed $1.1 billion annualized exit bookings. That ratio is useful for understanding the scale of investor expectations, but it is not a standard revenue multiple because bookings and recognized revenue are different.

Oura's reported revenue exceeded $1.4 billion over the trailing twelve months through June 2026, providing a stronger foundation for traditional financial valuation comparisons.

Investors are clearly paying a premium for Whoop's potential to turn high-priced subscriptions into long-term customer relationships. Whether those expectations are justified will become clearer when more detailed financial information is available.

Could Whoop catch Oura by expanding internationally?

International growth is one of Whoop's most promising opportunities to narrow the membership gap, particularly because its recent customer acquisition has become much more international.

According to Sports Business Journal's March 2026 reporting, approximately 60% of Whoop's new sales were coming from international markets. Four years earlier, around 30% of its users lived outside the United States.

Those percentages measure different things, so they cannot establish the exact change in Whoop's international membership share. Still, they suggest that the company's newest customers are increasingly coming from outside its home market.

Oura presents a contrasting picture. Its SEC filing reported that less than 20% of hardware revenue came from outside the United States during the nine months ending June 2026, even though the company operates across 56 markets.

Whoop appears to attract a much larger international share of recent sales, while Oura remains heavily dependent on U.S. hardware spending.

There are limits to what we can infer. International sales share is different from the number of international paying members, and neither company provides enough information to compare absolute overseas customer additions directly.

However, Whoop's international momentum gives it a credible route to faster growth in markets where Oura has not yet established the same level of consumer awareness and distribution.

Bar chart comparing Abridge's private valuation with Teladoc's market cap at each new valuation, Feb 2024 to Jun 2025: Abridge went from 35% of Teladoc's value to 3.8 times its value (Digital Health Market, NewMarketPitch)

Private startups are closing in on listed giants faster than most people think. See who's next in our digital health market report.

Are Apple, Samsung, and Garmin a bigger threat to Oura than Whoop?

Apple, Samsung, and Garmin may ultimately create more competitive pressure than Whoop because they can reach consumers through much larger hardware ecosystems.

Apple Watch combines health monitoring with fitness tracking, notifications, applications, and everyday smartwatch functions. Garmin is particularly strong among runners, cyclists, and endurance athletes who want detailed training information without paying a Whoop-style subscription for basic performance metrics.

Samsung is a more direct threat to Oura's hardware business. Galaxy Ring offers a similar form factor and benefits from the broader Galaxy ecosystem. RingConn and Ultrahuman also challenge the economics of owning a smart ring, particularly by offering alternatives without Oura's recurring membership charge.

These competitors attack different parts of the two companies' business models. Garmin can persuade serious athletes to choose a conventional sports watch instead of Whoop. Samsung can make buying an Oura ring less attractive to people already using Galaxy devices. Apple can compete for the entire daily health-tracking relationship.

Oura and Whoop therefore have strong positions within specific segments of the wearables market, but neither dominates health wearables overall.

Is Oura losing its lead to Whoop?

No. Oura still leads Whoop in verified paying customer scale and demonstrated financial performance, although Whoop has narrowed the gap in valuation and become a much more serious competitor in health monitoring.

The strongest evidence is Oura's continuing growth. Its paid membership reached 5 million by June 2026, roughly twice Whoop's last reported figure. Revenue increased approximately 74% across comparable nine-month periods, and the company reported positive net income, strong cash generation, and approximately 85% twelve-month member retention.

Whoop's progress is equally important to acknowledge. Its bookings doubled in 2025, its annualized exit bookings reached $1.1 billion, and its valuation climbed to $10.1 billion. It also has a strong athletic identity, increasingly capable hardware, and growing ambitions in preventive healthcare.

Oura has demonstrated that millions of consumers will buy its rings, pay for membership, and remain engaged. Whoop has demonstrated remarkable growth and the ability to attract customers willing to pay substantially more each year, but its financial and retention disclosures remain less complete.

Whoop could eventually close the gap through international expansion, broader health features, and continued subscription growth. To establish that it has actually overtaken Oura, we would need to see it surpass Oura in paying members or demonstrate a sustained financial advantage with comparable reporting.

For now, Whoop is catching up in strategic ambition and investor expectations. Oura remains the larger, better-documented business, and there is no convincing evidence that its customers are leaving for Whoop in meaningful numbers.

If you want more recent data on this point, please see our latest digital health market report.

Our methodology

This analysis assesses whether Oura is losing its competitive lead to Whoop using reported membership figures, revenue and bookings growth, profitability, retention, private-market valuations, product capabilities, and changes in the wider health-wearables market. We focus on whether Whoop's recent momentum corresponds to a measurable deterioration in Oura's position.

Our primary financial reference is Oura's September 2026 SEC Form S-1, supplemented by its amended filing and IPO announcement. These disclosures provide the basis for Oura's paid-member totals, revenue, net income, cash flow, customer retention, demographic composition, and geographic revenue distribution.

For Whoop, we use its March 2026 Series G financing announcement, which reported membership scale, the $10.1 billion valuation, 103% bookings growth, annualized exit bookings, and operating-cash-flow performance. We distinguish bookings from recognized revenue throughout the comparison. Oura's disclosed revenue and Whoop's annualized bookings cannot be treated as equivalent financial measures.

We also account for differences in reporting periods and definitions. Oura's 5 million paid members were reported for June 2026, while Whoop's more than 2.5 million members were reported in March. Oura's revenue growth covers comparable nine-month periods, whereas Whoop's bookings growth covers 2025. Private valuations are historical financing benchmarks rather than current, directly comparable public-market values. Three-year ownership costs assume unchanged standard U.S. prices, annual renewals, and no replacement hardware purchases.

To evaluate market position and product competition, we use IDC's wearable-device market intelligence, the 2025 Physiological Reports study comparing overnight wearable measurements, and official hardware information for Oura Ring 5 and Whoop 5.0 and MG. The independent physiological study is interpreted specifically for the hardware generations tested, without extending its results to newer devices.

Subscription and ownership-cost comparisons are based on Oura's hardware pricing, Oura's membership documentation, and Whoop's membership pricing. Competitive context also draws on Samsung's Galaxy Ring information and Garmin's Training Readiness documentation.

For preventive-health positioning, we reviewed Whoop's Healthspan documentation, Oura's health-software disclosures, and the FDA's July 2025 warning letter and June 2026 closeout letter concerning Whoop's Blood Pressure Insights. We distinguish the resolution of regulatory concerns from formal FDA clearance of a medical feature.

Finally, we weigh verified commercial performance more heavily than athlete endorsements, product marketing, or valuation headlines. The central tests are whether Whoop has closed Oura's paying-member gap, established a comparable financial advantage, or produced evidence that customers are leaving Oura in meaningful numbers. Our conclusion reflects the combined evidence across those measures rather than any single growth statistic.

Line chart of a listed digital health company's share price since a key event of the market: Since a weight-loss jab was approved, WeightWatchers lost almost all its value (Digital Health Market, NewMarketPitch)

When a market shifts, the old leaders don't always survive. We look at who's paying the price in our digital health market report.